Key facts
- Notable investors include Inuka Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for UniqueHuman
- ·The full record, as it builds
Funding rounds
No funding rounds for UniqueHuman are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UniqueHuman
Developer of a full-stack digital health platform intended to predict health flare ups early, triage disease management, and provide clinician integrated care. The company develops a Digital Health Twin for every individual: a living, learning model that transforms users unorganized health data from wearables, apps, and medical records to forecast health, enabling customers to receive crucial early warning alerts and precise, actionable recommendations to manage chronic conditions like migraines, ultimately transforming their health without the stress of figuring it all out themselves.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 2
- Website
- uniquehuman.ai/
- Ownership
- Privately Held (backing)
UniqueHuman doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UniqueHuman shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UniqueHuman in its N-PORT filings yet. We sweep new filings monthly.